Monday Market Highlights: 20 March 2023

Equity Trading Manager, 20 March 2023

In this week’s Monday Market Highlights, Dealer Will McVeagh looks into the US MOVE index and two-year bond yield, both impacted by moves triggered by the collapse of SVB and Signature Bank. He also discusses global investment bank Credit Suisse, and the US February CPI data released last week. In equity news, Will covers Neuren Pharmaceuticals’ phase 3 FDA approval for its drug to treat Rett Syndrome, and bus operator Kelsian’s move into the US market.

Listen to the podcast on your favourite platform:

Disclaimer: Milford is an active manager with views and portfolio positions subject to change. This blog is intended to provide general information only. It does not take into account your investment needs or personal circumstances. It is not intended to be viewed as investment or financial advice. Should you require financial advice you should always speak to a Financial Adviser. Past performance is not a guarantee of future performance.

Monday Market Highlights: 20 March 2023

Previous Milford on Newstalk ZB: 23 March 2023

Next Is this the start of another GFC?